Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancers|September 10, 2021
Targeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder CarcinomaChin-Li Chen, En Meng, Sheng-Tang Wu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effectCheri Enders Klein, Yi-Lin Chiu, Walid Awni, et al.
Journal of Clinical Pharmacology|April 29, 2008
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavirCheri E Klein, Yi-Lin Chiu, Yan Cai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2023
Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat strokeChih-Chin Shih, Wei-Chieh Liao, Hung-Yen Ke, et al.
AIDS Research and Human Retroviruses|March 19, 2009
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudineRafael E Campo, Barbara A Da Silva, Laurent Cotte, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2006
A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimenMargaret A Johnson, Joseph C Gathe, Daniel Podzamczer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2020
Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cellsShih-Hung Tsai, Lung-An Hsu, Hsiao-Ya Tsai, et al.
Pageof 9